Staging/ Classifications/ Stats Flashcards
What are the outcome for colon cancer (5 year survival)
Stage 1 (T1-2, N0) - >95%
Stage 2 (T3-4, N0) - 90%
Stage 3 (any T, N1-3) - 75%
Stage 4 (metastatic disease) - 15%
Amsterdam II criteria
These pts should have germline testing for Lynch Syndrome
- ≥ 3 relatives with a Lynch Syndrome associated cancer (colorectal, endometrium, small bowel, urothelium)
- ≥2 successive generations
- ≥1 with cancer diagnosis <50y.o
Staging parameters for sarcoma
Sacroma type
Tumour grade (mitosis, differentiation, tumour necrosis)
Tumour size
Nodal involvement (rare)
Involvement of distant sites
Spigelman classification
Points for
Polyp number (1,2,3)
Polyp size (1-4, 5-20, >20)
Histology (tubular, TV, villous)
Dysplasia (mild, moderate, severe)
Stage 0 (0 points) and Stage I (1-4 points) - endoscopy in 5 years
Stage II (5-6 points) - 2-3 years
Stage III (7-8 points) and stage IV (9-12 points) - repeat endoscopy 6-12 months and surgical evaluation
Which cancer genetic conditions have autosomal recessive inheritance?
ATM
MYH-associated adenomatous polyposis
Werner syndrome
Xeroderma pigmentosum
Screening for Lynch
Colonoscopy - annual from 25
Pelvic exam and endometrial sampling from 35
Ovarian USS from 35; consider BSO over 40
Gastroscopy 2-3 yearly from age 30-35
Annual uroanalysis from age 30-35
AAST Diaphragm injury scale
I - contusion
II - laceration <2cm
III - laceration 2-10cm
IV - laceration >10cm with tissue loss <25cm2
V - laceration is with tissue loss >25cm2
NF-1
Autosomal dominant
Mutation on chromosome 17
Loss of function mutation of neurofiromin
Clinical presentation:
Cafe-au-lait macules
Neurofibromas - cutaneous, nodular and plexiform
Freckling of axilla/groin
Lisch nodules (eyes, iris harmartomas)
Skeletal abnormalities (including kyphoscoliosis, sphenoid wing dysplasia and osteopenia)
Neurological abnormalities
Malignancies:
- neurological: optic nerve glioma, astrocytoma, Brainstem glioma and schwannomas
Wilms tumour
Rhadomyosarcoma
mPNSTs
Breast cancer
Melanoma
NF2
Neurofibromotosis type 2
Autosomal dominant
Chromosome 22
Loss of function mutation of protein Merlin, a tumour suppressor gene
Present with
Vestibular schwannomas
Meningomas
Spinal tumours